Sarcoidosis
ICD-10 D86 · ICD-11 4B20

Treatment of Sarcoidosis with Cutaneous Sarcoidosis: Several or Generalized Granulomatous Skin Lesions

Clinical Scenario

This protocol addresses patients with sarcoidosis who have developed specific granulomatous skin lesions that are several or generalized in extent — a presentation of cutaneous sarcoidosis where local therapy is no longer sufficient.

When This Protocol Applies

When granulomatous skin lesions do not respond to local therapy, or when cutaneous sarcoidosis is more generalized, systemic pharmacotherapy becomes necessary to achieve adequate disease control.

Treatment Approach (Partial Overview)

Systemic therapy is required; corticosteroids are typically considered at least in the short term, and steroid-sparing agents are an important part of longer-term management — the complete regimen and sequencing are in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

  1. If lesions do not respond to local therapy or if skin disease is more generalized, some type of pharmacotherapy is required.
  2. Systemic corticosteroids are usually used at least for the short term, but because of their many potential side effects, other agents should be considered for longer-term treatment.
  3. Hydroxychloroquine is often the first steroid-sparing drug used.
View source ↗